Cofrogliptin for preserving insulin-making cells in LADA
Treatments studied
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests whether a new medicine called cofrogliptin can help protect the cells that make insulin in people with LADA, a type of diabetes that often needs insulin treatment. It may help keep your own insulin production going longer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have been diagnosed with LADA, a type of diabetes that usually appears in adulthood and is linked to the immune system.
- You have not needed insulin continuously for at least 6 months after your diabetes diagnosis.
- Your body still makes some insulin (measured by a blood test called C-peptide).
- Your average blood sugar level (HbA1c) is 9.0% or lower.
- If you are a woman who could become pregnant, you must agree to use highly effective birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a hybrid closed-loop insulin pump system for people with LADA (a slow-progressing form of autoimmune diabetes). It aims to see if the system can improve blood sugar control and reduce hypoglycemia.
This study tests whether a natural supplement called berberine combined with inulin (a type of fiber) can help control blood sugar in adults with LADA, a form of diabetes. It aims to see if these supplements can improve diabetes care and potentially slow the need for insulin.
This trial tests two oral diabetes pills, cofrogliptin and linagliptin, when added to your current insulin treatment. The goal is to see if these pills help improve blood sugar control without causing extra side effects.
This trial compares adding a new pill (cofrogliptin) to increasing your current metformin dose, for people whose blood sugar is still too high despite taking an SGLT2 inhibitor and a low dose of metformin. The goal is to see which option works better and is safer.
This study tests an investigational pill (called cadisegliatin) added to your usual insulin treatment for people with type 1 diabetes who use an automated insulin pump. It aims to improve blood sugar control and reduce the time your sugar is too high.
This study compares two oral diabetes medicines, cofrogliptin and acarbose, to see which works better and has fewer side effects in people who are new to diabetes medication. If you qualify, you would take one of these pills daily, and the study will help you manage your blood sugar.
Hear when a new Latent Autoimmune Diabetes in Adults (LADA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.